Your browser doesn't support javascript.
loading
Falls: a marker of preclinical Alzheimer disease: a cohort study protocol.
Bollinger, Rebecca M; Keleman, Audrey; Thompson, Regina; Westerhaus, Elizabeth; Fagan, Anne M; Benzinger, Tammie Ls; Schindler, Suzanne E; Xiong, Chengjie; Balota, David; Morris, John C; Ances, Beau M; Stark, Susan L.
Afiliação
  • Bollinger RM; Program in Occupational Therapy, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Keleman A; Program in Occupational Therapy, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Thompson R; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Westerhaus E; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Fagan AM; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Benzinger TL; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Schindler SE; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Xiong C; Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Balota D; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Morris JC; Department of Psychological & Brain Sciences, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Ances BM; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Stark SL; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
BMJ Open ; 11(9): e050820, 2021 09 15.
Article em En | MEDLINE | ID: mdl-34526343
ABSTRACT

INTRODUCTION:

Progression to symptomatic Alzheimer disease (AD) occurs slowly over a series of preclinical stages. Declining functional mobility may be an early indicator of loss of brain network integration and may lead to an increased risk of experiencing falls. It is unknown whether measures of functional mobility and falls are preclinical markers of AD. The purpose of this study is to examine (1) the relationship between falls and functional mobility with AD biomarkers to determine when falls occur within the temporal progression to symptomatic Alzheimer disease, and (2) the attentional compared with perceptual/motor systems that underlie falls and functional mobility changes seen with AD. METHODS AND

ANALYSIS:

This longitudinal cohort study will be conducted at the Knight Alzheimer Disease Research Center. Approximately 350 cognitively normal participants (with and without preclinical AD) will complete an in-home visit every year for 4 years. During each yearly assessment, functional mobility will be assessed using the Performance Oriented Mobility Assessment, Timed Up and Go, and Timed Up and Go dual task. Data regarding falls (including number and severity) will be collected monthly by self-report and confirmed through interviews. This study will leverage ongoing neuropsychological assessments and neuroimaging (including molecular imaging using positron emission tomography and MRI) performed by the Knight Alzheimer Disease Research Center. Relationships between falls and biomarkers of amyloid, tau and neurodegeneration will be evaluated. ETHICS AND DISSEMINATION This study was approved by the Washington University in St. Louis Institutional Review Board (reference number 201807135). Written informed consent will be obtained in the home prior to the collection of any study data. Results will be published in peer-reviewed publications and presented at national and international conferences. TRIAL REGISTRATION NUMBER NCT04949529; Pre-results.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Aspecto: Ethics Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Aspecto: Ethics Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos